Target intelligence / Profile preview

Small intestinal epithelium

Molecular classification
Tissue, Cellular layer
01

Overview

The small intestinal epithelium is a specialized tissue layer that serves as the primary interface between the external environment and the internal systemic circulation. It is responsible for the digestion and absorption of nutrients, electrolytes, and water while simultaneously acting as a selective barrier against luminal pathogens and toxins (StatPearls, 2023). This complex layer is composed of various cell types, including absorptive enterocytes, mucus-secreting goblet cells, and hormone-producing enteroendocrine cells, all of which are essential for metabolic homeostasis (NIH, 2022). In conditions such as Celiac disease or inflammatory bowel disease, the structural integrity of the epithelium is compromised, leading to chronic inflammation and nutrient deficiencies (PubMed, 2021). While the epithelium itself is an anatomical structure rather than a single molecular target, it expresses numerous specific receptors and transporters, such as the GLP-2 receptor targeted by Teduglutide to treat short bowel syndrome (Nature Reviews Gastroenterology & Hepatology, 2020). Consequently, therapeutic interventions often focus on preserving this barrier or modulating the specific molecular pathways contained within its constituent cells (PubChem, 2023).

Other names
Intestinal mucosaSmall bowel epitheliumIntestinal liningEnteric epithelium
02

Mechanism of action

Drugs interacting with the small intestinal epithelium typically function by activating specific G protein-coupled receptors to promote mucosal growth, modulating apical ion channels to alter fluid secretion, or providing local anti-inflammatory effects to maintain barrier integrity.

03

Biological functions

Nutrient absorptionBarrier functionElectrolyte transportHormone secretionImmune surveillanceWater homeostasis
04

Disease associations

Celiac diseaseCrohn's diseaseMalabsorption syndromeEnteritisShort bowel syndromeIntestinal permeability (Leaky gut)
05

Safety considerations

MucositisAtrophyIncreased intestinal permeabilityMalabsorption of essential nutrientsBacterial translocation
06

Interacting drugs

Teduglutide

4 more in the full profile.

07

Biomarkers

Serum citrullineIntestinal fatty acid-binding protein (I-FABP)Fecal calprotectinZonulinDiamine oxidase

Beyond the preview

Go deeper on Small intestinal epithelium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small intestinal epithelium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call